Tariffs and Pharma: A Delicate Balance

This chapter delves into the effects of tariffs on the pharmaceutical industry within the scope of international trade discussions. It highlights the complexities of maintaining medication supply chains and the potential consequences for patient access amidst evolving manufacturing strategies. The conversation also assesses Donald Trump's tariff policies and their broader economic implications, including predictions of GDP impact and shifts in global manufacturing dynamics.